TIA1 and hepatocellular carcinoma: In agreement, our data indicate that TIA1 loss is associated with an increase in several secreted factors (e.g., S100 family members, osteopontin), which could potentially foster HCC development by promoting inflammation, hepatic fibrosis, and immune escape of cancer cells, as previously demonstrated [4].